Osteoanabolic Estrogen Therapy in a Transsexual Man

    Th. Hierl, I. Börcsök, Rosemarie Ziegler, Christian Kasperk
    Studysummary This case study found that in a male-to-female transgender individual, long-term cyproterone use led to decreased bone mass, which improved with additional oestradiol treatment, highlighting the anabolic role of oestrogens on bone health.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on thieme-connect.de →
    Discuss this study in the Community →